MCKESSON CORP

MCK · NYSE · SIC 5122: Wholesale-Drugs, Proprietaries & Druggists' Sundries · Market Cap: $104.9B · 51,000 employees
213
SEC Filings
$865.6
Close 2026-04-10
2
Transcripts
51,000
Employees

Business Summary

McKesson Corporation, tracing roots to 1833, is a diversified healthcare services company operating four segments: U.S. Pharmaceutical (distribution of branded, generic, specialty, biosimilar, and OTC drugs), Prescription Technology Solutions (medication access and affordability technology), Medical-Surgical Solutions (supply distribution to healthcare providers offering 245,000+ products), and International (distribution and retail pharmacy services in Canada and Norway). McKesson serves pharmacies, hospitals, oncology practices, biopharma companies, and governments.

Latest Stock Quote

MCK 2026-04-10 $865.6 O:$869.74 H:$873.195 L:$855.11 Vol:0.6M VWAP:$866.609
origin leaf: 9b3e2c2ade8e2d9a6f25f214db202f650d2cb93b415da593fd850e8fef74c8f3

Next Earnings

expected 2026-09-11

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionMCKdiscussed Cybersecurity
topic_mentionMCKdiscussed Regulation
topic_mentionMCKdiscussed Healthcare & Bio
topic_mentionMCKdiscussed Artificial Intelligence
topic_mentionMCKdiscussed Cybersecurity
topic_mentionMCKdiscussed Autonomous Vehicles
topic_mentionMCKdiscussed Capital Expenditure
topic_mentionMCKdiscussed Supply Chain
topic_mentionMCKdiscussed Regulation
topic_mentionMCKdiscussed Enterprise
topic_mentionMCKdiscussed Automotive
topic_mentionMCKdiscussed Healthcare & Bio
topic_mentionMCKdiscussed AI Compute
topic_mentionMCKdiscussed Platform & Ecosystem
metricMCK free cash flowreported $9.6 billion
guidanceMCKguided guidance range for interest expense to $215 million
guidanceMCKguided outlook includes plans to repurchase approximately $2.5 billion
outlookMCKstated We anticipate revenue gro wth of 12% to 16% and operating profit growth of 13% to 17%, reflecting our strong third quarter performance and the confidence that we
outlookMCKstated We anticipate revenue to increase 10% to 14% and operating profit to increase 8% to 12%
outlookMCKstated we anticipate continued growth of GLP - 1 medication

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-05-092025-03-310000927653-25-000036EDGAR78K words
2024-05-082024-03-310000927653-24-000035EDGAR—
2023-05-092023-03-310000927653-23-000038EDGAR—
2022-05-092022-03-310000927653-22-000051EDGAR—
2021-05-122021-03-310000927653-21-000039EDGAR—
2020-05-222020-03-310000927653-20-000033EDGAR—
2019-05-152019-03-310000927653-19-000009EDGAR—
2018-05-242018-03-310000927653-18-000010EDGAR—
2017-05-222017-03-310000927653-17-000007EDGAR—
2016-05-052016-03-310000927653-16-000020EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-02-042025-12-310000927653-26-000017EDGAR33K words
2025-11-062025-09-300000927653-25-000140EDGAR—
2025-08-062025-06-300000927653-25-000107EDGAR—
2025-02-062024-12-310000927653-25-000014EDGAR—
2024-11-072024-09-300000927653-24-000125EDGAR—
2024-08-072024-06-300000927653-24-000098EDGAR—
2024-02-082023-12-310000927653-24-000021EDGAR—
2023-11-022023-09-300000927653-23-000083EDGAR—
2023-08-022023-06-300000927653-23-000062EDGAR—
2023-02-022022-12-310000927653-23-000017EDGAR—
2022-11-022022-09-300000927653-22-000097EDGAR—
2022-08-042022-06-300000927653-22-000077EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-060000927653-26-000045EDGAR165K words
2026-03-060000927653-26-000038EDGAR—
2026-03-050000927653-26-000035EDGAR—
2026-02-040000927653-26-000015EDGAR—
2025-11-050000927653-25-000138EDGAR—
2025-09-230000927653-25-000125EDGAR—
2025-09-180000927653-25-000121EDGAR—
2025-08-060000927653-25-000105EDGAR—
2025-08-010000927653-25-000096EDGAR—
2025-06-090000927653-25-000045EDGAR—

213 total filings indexed. 181 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Earnings Transcripts

Call DateQuarterTitle
— MCK Earnings Call Transcript
— MCK Earnings Call Transcript

Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.

Sector Peers

CAH — CARDINAL HEALTH INC NASC — Can B Corp COR — Cencora, Inc. COSM — Cosmos Health Inc. HLF — HERBALIFE LTD. HWH — HWH International Inc. NUS — NU SKIN ENTERPRISES, INC. STEK — Stemtech Corp

Tags

pharmaceutical-distribution specialty-and-oncology-pharmacy medical-surgical-supply-distribution community-and-independent-pharmacy institutional-healthcare-providers biopharma-and-life-sciences prescription-technology-solutions international-pharmacy-and-distribution-(canada,-norway) retail-national-accounts home-health-care six-sigma-methodology

Company Identity

CIK0000927653
TickerMCK
ExchangeNYSE
SIC5122: Wholesale-Drugs, Proprietaries & Druggists' Sundries
IncorporatedDE
Websitehttps://www.mckesson.com
Listed1987-08-03

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 7692d12c75103b51d9a83653cb22bac14033a82ca8df5412565082208698e451
parent: f1c6304a750abe8003a060b8a0da8f455f5085efac08fab31e8f09732b226daf
content hash: 025057b56d2653e853f9e3b90d3baa1f5a9c5238661dcf664aa9302011e1d4b1
signed: 2026-04-13T04:46:11.813Z
sources: 25 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf